Discontinuation of primary and secondary prophylaxis for opportunistic infections in HIV-Infected Patients Who Had CD4+ Cell Count <200 cells/mm3 but Undetectable Plasma HIV-1 RNA: An Open-Label Randomized Controlled Trial

Discontinuation of primary and secondary prophylaxis for opportunistic infections in HIV-Infected Patients Who Had CD4+ Cell Count <200 cells/mm3 but Undetectable Plasma HIV-1 RNA: An Open-Label Randomized Controlled Trial

The CDC recommends discontinuing opportunistic infections (OIs) prophylaxis in HIV-infected patients who have CD4+ cell count > 200 cells/mm 3 after receiving combination antiretroviral therapy (cART). A prospective randomized controlled trial was conducted at Chiang Mai University Hospital fro...

Full description

Saved in:

Bibliographic Details
Main Authors:	Romanee Chaiwarith, Jutarat Praparattanapan, Nontakan Nuntachit, Wilai Kotarathitithum, Khuanchai Supparatpinyo
Format:	Journal
Published:	2018
Online Access:	https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84873335200&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/48123
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	Chiang Mai University

Similar Items

Discontinuation of primary and secondary prophylaxis for opportunistic infections in HIV-Infected Patients Who Had CD4+ Cell Count <200 cells/mm3 but Undetectable Plasma HIV-1 RNA: An Open-Label Randomized Controlled Trial
by: Romanee Chaiwarith, et al.
Published: (2018)

Discontinuation of primary and secondary prophylaxis for opportunistic infections in HIV-Infected Patients Who Had CD4+ Cell Count <200 cells/mm3 but Undetectable Plasma HIV-1 RNA: An Open-Label Randomized Controlled Trial
by: Chaiwarith R., et al.
Published: (2014)

Discontinuation of primary and secondary prophylaxis for opportunistic infections in HIV-infected patients who had CD4+ cell count <200 cells/mm(3) but undetectable plasma HIV-1 RNA: an open-label randomized controlled trial
by: Chaiwarith R., et al.
Published: (2014)

Impact of the frequency of plasma HIV-1 RNA monitoring on the outcome of antiretroviral therapy
by: Romanee Chaiwarith, et al.
Published: (2018)

Seroprevalence of antibodies to measles, mumps, and rubella, and serologic responses after vaccination among human immunodeficiency virus (HIV)-1 infected adults in northern thailand
by: Romanee Chaiwarith, et al.
Published: (2018)

Current molecular epidemiology and recombination of HIV type 1 subtypes in Northern Thailand
by: Jutarat Praparattanapan, et al.
Published: (2018)

Long-term CD4 cell count recovery among Thai naive HIV-infected patients initiating HAART at low CD4 cell count
by: Romanee Chaiwarith, et al.
Published: (2018)

Long-term CD4 cell count recovery among Thai naive HIV-infected patients initiating HAART at low CD4 cell count
by: Romanee Chaiwarith, et al.
Published: (2018)

Immunogenicity and safety of 4 vs. 3 standard doses of HBV vaccination in HIV-infected adults with isolated anti-HBc antibody
by: Nattinee Laksananun, et al.
Published: (2019)

Impact of HIV-1 viral load on genotypic characteristics among patients failing non-nucleoside reverse trancriptase inhibitor-based first-line regimens in Northern Thailand
by: Jutarat Praparattanapan, et al.
Published: (2018)

Itraconazole vs fluconazole as a primary prophylaxis for fungal infections in HIV-infected patients in Thailand
by: Romanee Chaiwarith, et al.
Published: (2018)

Characterization of anti-interferon-γ antibodies in HIV-negative immunodeficient patients infected with unusual intracellular microorganisms
by: Jiraprapa Wipasa, et al.
Published: (2018)

Characterization of anti-interferon-γ antibodies in HIV-negative immunodeficient patients infected with unusual intracellular microorganisms
by: Jiraprapa Wipasa, et al.
Published: (2018)

Higher rate of long-term serologic response of four double doses vs. standard doses of hepatitis B vaccination in HIV-infected adults: 4-year follow-up of a randomised controlled trial
by: Romanee Chaiwarith, et al.
Published: (2020)

Comparison of immunogenicity and safety of four doses and four double doses vs. standard doses of hepatitis B vaccination in HIV-infected adults: A randomized, controlled trial
by: Kanokporn Chaiklang, et al.
Published: (2018)

Comparison of immunogenicity and safety of four doses and four double doses vs. standard doses of hepatitis B vaccination in HIV-infected adults: A randomized, controlled trial
by: Kanokporn Chaiklang, et al.
Published: (2018)

Hepatitis B vaccination induced TNF-α- and IL-2-producing T cell responses in HIV. Healthy individuals higher than in HIV+ individuals who received the same vaccination regimen
by: Kriangkrai Chawansuntati, et al.
Published: (2018)

Resistance-associated mutations after initial antiretroviral treatment failure in a large cohort of patients infected with HIV-1 Subtype CRF01_AE
by: Praparattanapan,J., et al.
Published: (2015)

Resistance-Associated Mutations after Initial Antiretroviral Treatment Failure in a Large Cohort of Patients Infected with HIV-1 Subtype CRF01_AE
by: Praparattanapan J., et al.
Published: (2014)

Opportunistic infections in the liver of HIV-infected patients in Thailand: A necropsy study
by: Parnpen Viriyavejakul, et al.
Published: (2018)

Opportunistic protozoa in stool samples from HIV-infected patients
by: Benjanee Punpoowong, et al.
Published: (2018)

Clinical and laboratory characteristics of penicilliosis marneffei among patients with and without HIV infection in Northern Thailand: A retrospective study
by: Rathakarn Kawila, et al.
Published: (2018)

Clinical and laboratory characteristics of penicilliosis marneffei among patients with and without HIV infection in Northern Thailand: A retrospective study
by: Rathakarn Kawila, et al.
Published: (2018)

Opportunistic intestinal parasite infection and mode of sexual intercourse of HIV-infected patients in the era of HAART
by: Viroj Wiwanitkit, et al.
Published: (2018)

Treatment of opportunistic infections prior to HAART initiation does not affect immune reconstitution in HIV-infected patients
by: Sakorn Pornprasert, et al.
Published: (2018)

Treatment of opportunistic infections prior to HAART initiation does not affect immune reconstitution in HIV-infected patients
by: Pornprasert S., et al.
Published: (2017)

Impact of antiretroviral therapy on opportunistic infections of HIV-infected children in the therapeutic research, education and aids training asia pediatric HIV observational database
by: Wasana Prasitsuebsai, et al.
Published: (2018)

Impact of antiretroviral therapy on opportunistic infections of HIV-infected children in the therapeutic research, education and aids training asia pediatric HIV observational database
by: Wasana Prasitsuebsai, et al.
Published: (2018)

Impact of antiretroviral therapy on opportunistic infections of HIV-infected children in the therapeutic research, education and aids training asia pediatric HIV observational database
by: Wasana Prasitsuebsai, et al.
Published: (2018)

Impact of the frequency of plasma HIV-1 RNA monitoring on the outcome of antiretroviral therapy
by: Chaiwarith R., et al.
Published: (2014)

Long-term CD4 cell count recovery among Thai naive HIV-infected patients initiating HAART at low CD4 cell count
by: Chaiwarith R., et al.
Published: (2014)

Disseminated nontuberculous mycobacterial infection in patients who are not infected with HIV in Thailand
by: Ploenchan Chetchotisakd, et al.
Published: (2018)

Disseminated nontuberculous mycobacterial infection in patients who are not infected with HIV in Thailand
by: Ploenchan Chetchotisakd, et al.
Published: (2018)

Incidence and risk factors of antiretroviral treatment failure in treatment-naïve HIV-infected patients at Chiang Mai University Hospital, Thailand
by: Nitta Khienprasit, et al.
Published: (2018)

Comparison of in-house HIV-1 genotypic drug resistant test with commercial HIV-1 genotypic test kit
by: Praparattanapan,J., et al.
Published: (2015)

Comparison of in-house HIV-1 genotypic drug resistant test with commercial HIV-1 genotypic test kit
by: Praparattanapan,J., et al.
Published: (2015)

Seroprevalence of antibodies to measles, mumps, and rubella, and serologic responses after vaccination among human immunodeficiency virus (HIV)-1 infected adults in northern thailand
by: Chaiwarith R., et al.
Published: (2017)

Thymic function during 12 months of highly active antiretroviral therapy in Thai HIV-infected patients with normal and slow immune recovery
by: Doungnapa Kingkeow, et al.
Published: (2018)

Thymic function during 12 months of highly active antiretroviral therapy in Thai HIV-infected patients with normal and slow immune recovery
by: Doungnapa Kingkeow, et al.
Published: (2018)

Itraconazole vs fluconazole as a primary prophylaxis for fungal infections in HIV-infected patients in Thailand
by: Chaiwarith R., et al.
Published: (2014)